Like other tissues of the central nervous system, the retina is susceptible to damage by oxidative processes that result in several neurodegenerative disease such as age-related macular degeneration, diabetic retinopathy, glaucoma, ischaemic retinal disease, retinal disease produced by light oxidation, and detached retina, among other diseases. The use of antioxidant substances is a solution to some health problems caused by oxidative stress, because they regulate redox homeostasis and reduce oxidative stress. This is important for neurodegeneration linked to oxidation processes. In line with this, Ginkgo biloba is a medicinal plant with excellent antioxidant properties whose effects have been demonstrated in several degenerative processes, including retinal diseases associated with neurodegeneration. This review describes the current literature on the role of ginkgo in retinal diseases associated with neurodegeneration. The information leads to the conclusion that G. biloba extracts might be a good option to improve certain neurodegenerative retinal diseases, but more research is needed to determine the safety and efficacy of G. biloba in these retinal degenerative processes.
The retina may suffer neurodegenerative damages, as other tissues of the central nervous system do, and serious eye diseases may develop. One of them is age-related macular degeneration, which causes progressive loss of vision due to retina degeneration. Treatment of age-related macular degeneration focuses on antioxidant agents and anti-vascular endothelial growth factor compounds, among others, that prevent/diminish oxidative stress and reduce neovascularisation respectively. The phytochemicals, medicinal plants and/or plant-diet supplements might be a useful adjunct in prevention or treatment of age-related macular degeneration owing to their antioxidant and anti-vascular endothelial growth factor properties. This review article presents the most investigated plants and natural products in relation to age-related macular degeneration, such as saffron, ginkgo, bilberry and blueberry, curcuma or turmeric, carotenoids, polyphenols, and vitamins C and E. This study provides up-to-date information on the effects, treatments, safety and efficiency of these phytotherapy products.
Vitis vinifera is a plant known since ancient times mainly for the interest of its fruits. However, its leaves have traditionally been consumed as food in some regions of the Mediterranean basin and as a medicinal remedy. In this work, the phytochemical profile of this part of the plant, which is considered a bio-residue of viticultural processes, was analyzed (UHPLC-ESI(±)-QTOF-MS). Hydroxybenzoic acids, flavonols, and stilbenes are the main phenolic compounds identified. Its antioxidant and anti-inflammatory capacity were studied both in vitro and in cell culture. Grapevine leaves have a high capacity to scavenge free radicals, as well as to reduce oxidative stress induced by H2O2 in the HepG2 cell line. On the other hand, the methanolic extract of these leaves is capable of inhibiting lipoxygenase, an enzyme involved in inflammatory responses, with an IC50 of 1.63 μg/mL. In addition, the extract showed potent inhibition of NO production in LPS-stimulated RAW 264.7 cells. These results pointed out V. vinifera leaves as a powerful functional food with a high content of biologically active compounds. The enhancement of these by-products can be highly beneficial to food systems and contribute to the development of sustainable agriculture.
Background: There is ample scientific evidence to support that tobacco consumption is associated with diseases such as chronic obstructive pulmonary disease (COPD), bronchitis, and cancer. However, few studies have compared the harm caused by different types of tobacco, such as black and blond tobacco (BlaT, BloT). Objective: This study aims to search for the potential links between type of tobacco, dosage, tobacco consumption time, and disease. Methods: A longitudinal retrospective case–control study (163:162) was conducted using clinical histories and telephone interviews. Disproportions (prevalence, OR, and crude OR), dose and years of smoking (ANOVA), and strata (tobacco type, dose, and time) (Reg. Log. Bin. Cox) were used. Results: A significant correlation was discovered between smoking, type of tobacco, and disease, particularly for COPD. The OR for BlaT/non-smokers was 64.62 and for BloT/non-smokers was 26.44. When stratified by tobacco type, the crude OR for BlaT was 8.38 for COPD, 7.82 for bronchitis, and 2.25 for cancer. Cox R analysis revealed a dose–response relationship between smoking and time, with BlaT having Cox R values of 88.41 for COPD and 3.95 for cancer. Conclusion: The main conclusion is that while all types of tobacco are harmful, BlaT is even more harmful than BloT.